Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Updates in Surgery

Open Access 12-04-2025 | Obesity | Review Article

Preoperative weight loss by noninvasive approach in patients with obesity scheduled for bariatric and metabolic surgery: an update narrative review of indications and results available until 2024

Authors: Ilenia Grandone, Monica Nannipieri, Caterina Conte, Edda Cava, Luigi Schiavo

Published in: Updates in Surgery

Login to get access

Abstract

Metabolic and bariatric surgery (MBS) is the most effective treatment for severe obesity and its metabolic complications. Currently, most MBSs are performed laparoscopically. However, high weight associated with an enlarged liver (especially the left lobe liver section, LLLS) may complicate the technical aspects of this surgery. Therefore, before MBS, moderate preoperative weight loss (PreopWL), and reduction in LLLS are desirable. Moreover, studies are inconclusive regarding which is the best approach to apply. This narrative review aimed to describe the current scientific evidence on the effect of a noninvasive approach, such as dietary or pharmacotherapy or space-occupying devices on PreopWL, peri-operative complications, hospital length of stay, and post-operative complications in patients with obesity scheduled for MBS. We conducted a literature search and screening for relevant publications from January 2010 to June 2024. We found that PreopWL before MBS is helpful for both patients and surgeons, as it leads to various benefits, such as a decrease in body weight and LLLS size, a lower risk of intra- and post-operative complications, shorter surgery times, and reduced hospital stays. In this context, concerning dietary approaches, several dietary protocols have been introduced over time, among which very low-calorie diets and very low energy ketogenic therapy are widely prescribed; however, larger randomized-controlled trials (RCTs) with well-defined dietary protocols are necessary to make definitive conclusions. Obesity management medications, such as the lipase inhibitor orlistat, phentermine/topiramate, naltrexone/bupropion, the glucagon-like peptide-1 receptor agonists (GLP-1RAs) liraglutide and semaglutide, and the novel dual glucose dependent insulinotropic peptide (GIP)/GLP-1 receptor agonist tirzepatide, has shown to be effective in promoting PreopWL before MBS; however, larger, well-designed RCTs are needed to establish optimal treatment protocols and assess their true benefits in patients scheduled for MBS. Space-occupying devices such as the swallowable intragastric balloon and hydrogel capsules, represent a promising tools but further research is essential to confirm their role.
Literature
1.
Rajabi MR, Rezaei M, Abdollahi A, Gholi Z, Mokhber S, Mohammadi-Farsani G, Abdoli D, Mousavi SD, Amini H, Ghandchi M (2024) Long-term systemic effects of metabolic bariatric surgery: a multidisciplinary perspective. Heliyon 10(14):e34339PubMedPubMedCentralCrossRef
2.
Brethauer S (2011) ASMBS position statement on preoperative supervised weight loss requirements. Surg Obes Relat Dis. 7(3):257–260PubMedCrossRef
3.
Samaan JS, Zhao J, Qian E, Hernandez A, Toubat O, Alicuben ET, Malik Y, Sandhu K, Dobrowolsky A, Samakar K (2022) Preoperative weight loss as a predictor of bariatric surgery postoperative weight loss and complications. J Gastrointest Surg 26(1):86–93PubMedCrossRef
4.
Reed BL, Jackson DG, Lilly C, Abunnaja S, Tabone LE, Szoka NL (2023) Preoperative weight loss as a predictor of short and midterm postoperative weight loss in patients undergoing bariatric surgery. Bariatr Surg Pract Patient Care 18(1):8–12PubMedPubMedCentralCrossRef
5.
Krimpuri RD, Yokley JM, Seeholzer EL, Horwath EL, Thomas CL, Bardaro SJ (2018) Qualifying for bariatric surgery: is preoperative weight loss a reliable predictor of postoperative weight loss? Surg Obes Relat Dis 14(1):60–64PubMedCrossRef
6.
Sarno G, Calabrese P, Frias-Toral E, Ceriani F, Fuchs-Tarlovsky V, Spagnuolo M, Cucalón G, Córdova LÁ, Schiavo L, Pilone V (2023) The relationship between preoperative weight loss and intra and post-bariatric surgery complications: an appraisal of the current preoperative nutritional strategies. Crit Rev Food Sci Nutr 63(29):10230–10238PubMedCrossRef
7.
Iannelli A, Fontas E, Grec L, Nocca D, Robert M, Schiavo L, Schneck AS (2022) Four-week omega-3 polyunsaturated fatty acids supplementation for liver left lateral section volume reduction in individuals with morbid obesity undergoing bariatric surgery: a double blind, multicenter, randomized placebo-controlled trial. Int J Surg 101:106614PubMedCrossRef
8.
Schiavo L, Pilone V, Rossetti G, Barbarisi A, Cesaretti M, Iannelli A (2018) A 4-week preoperative ketogenic micronutrient-enriched diet is effective in reducing body weight, left hepatic lobe volume, and micronutrient deficiencies in patients undergoing bariatric surgery: a prospective pilot study. Obes Surg 28(8):2215–2224PubMedCrossRef
9.
10.
Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE (2006) Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 84(2):304–311PubMedCrossRef
11.
Lewis MC, Phillips ML, Slavotinek JP, Kow L, Thompson CH, Toouli J (2006) Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg 16(6):697–701PubMedCrossRef
12.
Barrea L, Verde L, Schiavo L, Sarno G, Camajani E, Iannelli A, Caprio M, Pilone V, Colao A, Muscogiuri G (2023) Very low-calorie ketogenic diet (VLCKD) as pre-operative first-line dietary therapy in patients with obesity who are candidates for bariatric surgery. Nutrients 15(8):1907PubMedPubMedCentralCrossRef
13.
Brody F, Vaziri K, Garey C et al (2011) Preoperative liver reduction utilizing a novel nutritional supplement. J Laparoendosc Adv Surg Tech A 21(6):491–495PubMedCrossRef
14.
Santella B, Mingo M, Papp A, Rice M, Chiappetta S, Calabrese P, Calenda F, Pilone V, Schiavo L (2024) Safety and effectiveness of a 4-week diet on low-carb ready-to-eat ketogenic products as preoperative care treatment in patients scheduled for metabolic and bariatric surgery. Nutrients 16(22):3875PubMedPubMedCentralCrossRef
15.
Schiavo L, Pierro R, Asteria C, Calabrese P, Di Biasio A, Coluzzi I, Severino L, Giovanelli A, Pilone V, Silecchia G (2022) Low-calorie ketogenic diet with continuous positive airway pressure to alleviate severe obstructive sleep apnea syndrome in patients with obesity scheduled for bariatric/metabolic surgery: a pilot, prospective randomized multicenter comparative study. Obes Surg 32(3):634–642PubMedCrossRef
16.
Castaldo G, Schiavo L, Pagano I, Molettieri P, Conte A, Sarno G, Pilone V, Rastrelli L (2023) Clinical impact of enteral protein nutritional therapy on patients with obesity scheduled for bariatric surgery: a focus on safety, efficacy, and pathophysiological changes. Nutrients 15(6):1492PubMedPubMedCentralCrossRef
17.
Pilone V, Tramontano S, Renzulli M, Romano M, Cobellis L, Berselli T, Schiavo L (2018) Metabolic effects, safety, and acceptability of very low-calorie ketogenic dietetic scheme on candidates for bariatric surgery. Surg Obes Relat Dis 14(7):1013–1019PubMedCrossRef
18.
Schiavo L, De Stefano G, Persico F, Gargiulo S, Di Spirito F, Griguolo G, Petrucciani N, Fontas E, Iannelli A, Pilone V (2021) A randomized, controlled trial comparing the impact of a low-calorie ketogenic vs a standard low-calorie diet on fat-free mass in patients receiving an Elipse™ intragastric balloon treatment. Obes Surg 31(4):1514–1523PubMedCrossRef
19.
Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S (2019) Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2: a systematic review and meta-analysis. Surg Endosc 33(11):3578–3588PubMedCrossRef
20.
Sudlow AC, le Roux CW, Pournaras DJ (2019) Review of advances in anti-obesity pharmacotherapy: implications for a multimodal treatment approach with metabolic surgery. Obes Surg 29(12):4095–4104CrossRef
21.
Schiavo L, Scalera G, Sergio R, De Sena G, Pilone V, Barbarisi A (2015) Clinical impact of Mediterranean-enriched-protein diet on liver size, visceral fat, fat mass, and fat-free mass in patients undergoing sleeve gastrectomy. Surg Obes Relat Dis 11(5):1164–1170PubMedCrossRef
22.
Schwartz ML, Drew RL, Chazin-Caldie M (2004) Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass. Obes Surg 14(9):1193–1197PubMedCrossRef
23.
Albanese A, Prevedello L, Markovich M, Busetto L, Vettor R, Foletto M (2019) Pre-operative very low calorie ketogenic diet (VLCKD) vs. very low calorie diet (VLCD): surgical impact. Obes Surg 29(1):292–296PubMedCrossRef
24.
Tsai AG, Wadden TA (2006) The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring) 14(8):1283–1293PubMedCrossRef
25.
McKechnie T, Lee Y, Dionne J, Doumouras A, Parpia S, Bhandari M, Eskicioglu C (2023) Very low energy diets prior to bariatric surgery may reduce postoperative morbidity: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 20(10):1211575CrossRef
26.
Güçlü D, Işıksaçan N, Seyit H et al (2024) Effect of diet before bariatric surgery on ghrelin level through DNA methylation. Ann Nutr Metab 80(3):153–160PubMedCrossRef
27.
28.
Leonetti F, Campanile FC, Coccia F, Capoccia D, Alessandroni L, Puzziello A, Coluzzi I, Silecchia G (2015) Very low-carbohydrate ketogenic diet before bariatric surgery: prospective evaluation of a sequential diet. Obes Surg 25(1):64–71PubMedCrossRef
29.
Simancas-Racines D, Frias-Toral E, Campuzano-Donoso M et al (2025) Preoperative nutrition in bariatric surgery: a narrative review on enhancing surgical success and patient outcomes. Nutrients 17(3):566PubMedPubMedCentralCrossRef
30.
Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A et al (2011) Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 146(11):1300–1305PubMedCrossRef
31.
Kalarchian MA, Marcus MD, Courcoulas AP, Cheng Y, Levine MD (2016) Preoperative lifestyle intervention in bariatric surgery: a randomized clinical trial. Surg Obes Relat Dis 12(1):180–187PubMedCrossRef
32.
Mechanick JI, Apovian C, Brethauer S et al (2020) Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring) 28(4):O1–O58PubMedCrossRef
33.
34.
Khalooeifard R, Rahmani J, Ghoreishy SM, Tavakoli A, Najjari K, Talebpour M (2024) Evaluate the effects of different types of preoperative restricted calorie diets on weight, body mass index, operation time and hospital stay in patients undergoing bariatric surgery: a systematic review and meta analysis study. Obes Surg 34(1):236–249PubMedCrossRef
35.
36.
Alabduljabbar K, le Roux CW (2023) Pharmacotherapy before and after bariatric surgery. Metabolism 148:155692PubMedCrossRef
37.
38.
Sher T, McGee M, DuCoin C, Sujka J, Docimo S Jr (2024) Evaluating the use of adjuvant and neoadjuvant terminology in bariatric surgery: a scoping review. J Gastrointest Surg 28(6):966–974PubMedCrossRef
39.
Malone M, Alger-Mayer SA, Lindstrom J (2012) Use of Orlistat 60 mg in the management of weight loss before bariatric surgery. Ann Pharmacother 46(6):779–784PubMedCrossRef
40.
Lo HC, Hsu SC (2023) Effectiveness of a preoperative orlistat-based weight management plan and its impact on the results of one-anastomosis gastric bypass: a retrospective study. PLoS One 18(7):e0289006PubMedPubMedCentralCrossRef
41.
Ard JD, Beavers DP, Hale E, Miller G, McNatt S, Fernandez A (2019) Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m2 or more. Surg Obes Relat Dis 15(7):1039–1043PubMedCrossRef
42.
Cunningham JG, Szoka N, Tabone LE, Cox S, Aylward L, Abunnaja S (2023) Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery. Surg Obes Relat Dis 19(8):832–840PubMedCrossRef
43.
Stier C, Koschker AC, Kim M, Stier R, Chiappetta S, Stein J (2022) Fast-track rescue weight reduction therapy to achieve rapid technical operability for emergency bariatric surgery in patients with life-threatening inoperable severe obesity—a proof of concept study. Clin Nutr ESPEN 50:238–246PubMedCrossRef
44.
Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH (2023) New insights into the treatment of obesity. Diabetes Obes Metab 25(8):2058–2072PubMedCrossRef
45.
Ilanga M, Heard JC, McClintic J, Lewis D, Martin G, Horn C, Khorgami Z, Richards J, Chow GS, Lim RB (2023) Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. Surg Endosc 37(12):9509–9513PubMedCrossRef
46.
Martines G, Dezi A, Giove C, Lantone V, Rotelli MT, Picciariello A, Tomasicchio G (2023) Efficacy of intragastric balloon versus liraglutide as bridge to surgery in super-obese patients. Obes Facts 16(5):457–464PubMedPubMedCentralCrossRef
47.
Rubio-Herrera MA, Mera-Carreiro S, Sánchez-Pernaute A, Ramos-Levi AM (2023) Impact of treatment with GLP1 receptor agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, while on a waiting list for bariatric surgery. Biomedicines. 11(10):2785PubMedPubMedCentralCrossRef
48.
Muñoz MPS, Blandón JDR, Gutierrez ISC, Mendoza CMM, Aguiñaga MSA, Orozco CAO (2024) Liraglutide effectiveness in preoperative weight-loss for patients with severe obesity undergoing bariatric-metabolic surgery. Updates Surg 76(6):2277–2283PubMedCrossRef
49.
Hakim M, Fathi M, Abdulraziq M, Al SM (2022) Incidence of adhesions in patients using liraglutide before laparoscopic sleeve gastrectomy. Surg Endosc 36(11):8503–8508PubMedCrossRef
50.
Mrad R, Al Annan K, Sayegh L, Abboud DM, Razzak FA, Kerbage A, Murad MH, Abu Dayyeh B, Brunaldi VO (2024) Comparative effectiveness of balloons, adjustable balloons, and endoscopic sleeve gastroplasty: a network meta-analysis of randomized trials. Gastrointest Endosc S0016–5107(24):03638–03641
51.
Silva AF, Bestetti AM, Kum AST, Nunes BCM, de Oliveira VM, Bernardo WM, de Moura EGH (2024) Effectiveness and safety of the allurion swallowable intragastric balloon for short-term weight loss: a systematic review and meta-analysis. Obes Surg 34(10):3735–3747PubMedCrossRef
52.
Espinet-Coll E, Del Pozo-García AJ, Turró-Arau R, Nebreda-Durán J, Cortés-Rizo X, Serrano-Jiménez A, Escartí-Usó MÁ, Muñoz-Tornero M, Carral-Martínez D, Bernabéu-López J, Sierra-Bernal C, Martínez-Ares D, Espinel-Díez J, Marra-López Valenciano C, Sola-Vera J, Sanchís-Artero L, Domínguez-Jiménez JL, Carreño-Macián R, Juanmartiñena-Fernández JF, Fernández-Zulueta A, Consiglieri-Alvarado C, Galvao-Neto M; Collaborators for the “Spanish Bariatric Endoscopy Group (GETTEMO) of the Spanish Society of Digestive Endoscopy (SEED)” (2024) Evaluating the safety of the intragastric balloon: spanish multicenter experience in 20,680 cases and with 12 different balloon models. Obes Surg 34(8):2766–2777
53.
Ienca R, Al Jarallah M, Caballero A, Giardiello C, Rosa M, Kolmer S, Sebbag H, Hansoulle J, Quartararo G, Zouaghi SAS, Juneja G, Murcia S, Turro R, Pagan A, Badiuddin F, Dargent J, Urbain P, Paveliu S, di Cola RS, Selvaggio C, Al KM (2020) The procedureless elipse gastric balloon program: multicenter experience in 1770 consecutive patients. Obes Surg 30(9):3354–3362. https://​doi.​org/​10.​1007/​s11695-020-04539-8. (Erratum.In:ObesSurg.2020Sep;30(9):3363-3364.doi:10.1007/s11695-020-04640-y.Erratumin:ObesSurg.2020Nov;30(11):4691-4692)CrossRefPubMedPubMedCentral
54.
Tønnesen CJ, Hjelmesæth J, Hofsø D, Tonstad S, Hertel JK, Heggen E, Johnson LK, Mathisen TE, Kalager M, Wieszczy P, Medhus AW, Løberg M, Aabakken L, Bretthauer M (2022) A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial. Scand J Gastroenterol 57(2):232–238PubMedCrossRef
55.
Patiño Araujo B, Duque Jácome KE, Salgado Báez ME, Villavicencio Logroño G, Salgado MN (2024) Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience. Clin Obes 22:e12705
56.
Jense MTF, Palm-Meinders IH, Sanders B, Boerma EG, Greve JWM (2023) The swallowable intragastric balloon combined with lifestyle coaching: short-term results of a safe and effective weight loss treatment for people living with overweight and obesity. Obes Surg 33(6):1668–1675PubMedPubMedCentralCrossRef
57.
Shirin H, Richter V, Matalon S, Abramowich D, Maliar A, Shachar E, Moss SF, Broide E (2019) Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity. Obes Sci Pract 5(4):376–382PubMedPubMedCentralCrossRef
58.
Greenway FL, Aronne LJ, Raben A, Astrup A, Apovian CM, Hill JO, Kaplan LM, Fujioka K, Matejkova E, Svacina S, Luzi L, Gnessi L, Navas-Carretero S, Alfredo Martinez J, Still CD, Sannino A, Saponaro C, Demitri C, Urban LE, Leider H, Chiquette E, Ron ES, Zohar Y, Heshmati HM (2019) A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Obesity (Silver Spring). 2019;27(2):205–216. https://​doi.​org/​10.​1002/​oby.​22347. Epub 2018 Nov 13. Erratum in: Obesity (Silver Spring). 2019 Apr;27(4):679. https://​doi.​org/​10.​1002/​oby.​22445. Erratum in: Obesity (Silver Spring). 2019 Jul;27(7):1210
59.
Reister EJ, Mattes RD (2022) No apparent effects of a viscous, superabsorbent hydrogel on appetite, energy intake, or fecal excretion in overweight adults. Physiol Behav 1(243):113643CrossRef
60.
Shirin H, Neeland IJ, Ryan DH, de Luis D, Lecube A, Magos Z, Kenan Y, Amir R, Cohen DL, Johansen OE (2023) Effects of an oral biodegradable device used for 12 weeks on weight reduction, cardiovascular risk factors, satiety, snacking, and meal size. Obes Pillars 13(8):100094CrossRef
Metadata
Title
Preoperative weight loss by noninvasive approach in patients with obesity scheduled for bariatric and metabolic surgery: an update narrative review of indications and results available until 2024
Authors
Ilenia Grandone
Monica Nannipieri
Caterina Conte
Edda Cava
Luigi Schiavo
Publication date
12-04-2025
Publisher
Springer International Publishing
Published in
Updates in Surgery
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-025-02198-x
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video
Image Credits